News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
70,128 Results
Type
Article (1930)
Company Profile (2)
Press Release (68196)
Section
Business (21499)
Career Advice (9)
Deals (4564)
Drug Development (8173)
FDA (1810)
Job Trends (806)
News (37090)
Policy (3566)
Tag
Academia (93)
Allergies (5)
Alliances (8149)
ALS (6)
Alzheimer's disease (123)
Antibody-drug conjugate (ADC) (13)
Approvals (1841)
Artificial intelligence (14)
Automation (1)
Bankruptcy (8)
Best Places to Work (589)
Biosimilars (22)
Biotechnology (5)
Bladder cancer (11)
Brain cancer (2)
Breast cancer (21)
Cancer (222)
Cardiovascular disease (5)
Career advice (9)
CAR-T (4)
Cell therapy (25)
Clinical research (7048)
Collaboration (94)
Compensation (9)
Complete response letters (2)
COVID-19 (187)
C-suite (16)
Cystic fibrosis (4)
Data (202)
Depression (1)
Diabetes (14)
Diagnostics (600)
Digital health (1)
Drug discovery (13)
Duchenne muscular dystrophy (12)
Earnings (7656)
Events (7016)
Executive appointments (49)
FDA (1961)
Fibrodysplasia Ossificans Progressiva (1)
Funding (60)
Gene editing (3)
Gene therapy (19)
GLP-1 (45)
Government (233)
Grass and pollen (1)
Guidances (4)
Healthcare (1077)
IgA nephropathy (4)
Immunology and inflammation (1)
Indications (3)
Infectious disease (194)
Inflammatory bowel disease (17)
Influenza (6)
Intellectual property (17)
IPO (1628)
Job creations (243)
Job search strategy (9)
Layoffs (6)
Legal (954)
Liver cancer (16)
Lung cancer (36)
Lymphoma (15)
Manufacturing (31)
MASH (7)
Medical device (1131)
Medtech (1132)
Mergers & acquisitions (3033)
Metabolic disorders (39)
Multiple sclerosis (8)
NASH (1)
Neurodegenerative disease (7)
Neuroscience (168)
NextGen: Class of 2025 (221)
Non-profit (62)
Obesity (16)
Opinion (1)
Ovarian cancer (10)
Pain (4)
Pancreatic cancer (8)
Parkinson's disease (15)
Partnered (2)
Patents (19)
Patient recruitment (9)
People (4973)
Pharmaceutical (3)
Phase I (1913)
Phase II (2955)
Phase III (2671)
Pipeline (125)
Postmarket research (241)
Preclinical (667)
Press Release (2)
Prostate cancer (8)
Radiopharmaceuticals (22)
Rare diseases (27)
Real estate (602)
Regulatory (2606)
Reports (6)
Research institute (92)
Schizophrenia (7)
Series A (15)
Series B (7)
Service/supplier (1)
Sickle cell disease (1)
Spinal muscular atrophy (4)
Startups (423)
Stomach cancer (1)
Supply chain (8)
Vaccines (25)
Venture capitalists (2)
Weight loss (2)
Women's health (1)
Date
Today (12)
Last 7 days (72)
Last 30 days (216)
Last 365 days (2927)
2025 (897)
2024 (3267)
2023 (3822)
2022 (7020)
2021 (6389)
2020 (5878)
2019 (3875)
2018 (3011)
2017 (3568)
2016 (3177)
2015 (4046)
2014 (3031)
2013 (2602)
2012 (2779)
2011 (2914)
2010 (2666)
Location
Africa (79)
Alabama (1)
Arizona (8)
Asia (21418)
Australia (2479)
California (355)
Canada (232)
China (166)
Colorado (4)
Connecticut (14)
Delaware (4)
Europe (12476)
Florida (22)
Georgia (8)
Illinois (16)
India (11)
Indiana (4)
Japan (82)
Kansas (5)
Louisiana (1)
Maine (4)
Maryland (75)
Massachusetts (243)
Michigan (2)
Minnesota (27)
Missouri (3)
Nebraska (1)
Nevada (1)
New Jersey (203)
New York (149)
North Carolina (61)
Northern California (141)
Ohio (2)
Oregon (1)
Pennsylvania (55)
South America (108)
Southern California (162)
Tennessee (1)
Texas (28)
United States (1334)
Utah (13)
Virginia (25)
Washington D.C. (2)
Washington State (17)
Wisconsin (6)
70,128 Results for "speedx pty ltd".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
NanoVibronix Announces Renewal and Expansion of Distribution Agreement with Dukehill Healthcare Pty Ltd in Australia
April 2, 2025
·
5 min read
Press Releases
SpeeDx Appoints Jeremy Stackawitz as Chief Executive Officer to Drive Global Expansion of Its Molecular Diagnostics Solutions
October 24, 2024
·
2 min read
Press Releases
Halia Therapeutics Joins Forces with Southern Star Research Pty Ltd to Advance Clinical Development of Novel LRRK2 Inhibitor, HT-4253 for Neurodegenerative Diseases
September 3, 2024
·
4 min read
Press Releases
Medicus Pharma Ltd. Announces a Binding Letter of Intent to Acquire Antev Ltd. for ~US$75 Million in a Share Exchange Transaction
Antev Shareholders to Receive Aggregate ~19% Equity Stake in Medicus, Plus US$65 Million in Contingent Payments
April 28, 2025
·
10 min read
Press Releases
Kairos Pharma Ltd. Provides Letter to Stockholders
April 24, 2025
·
5 min read
Drug Development
SpeeDx Expand COVID-19 Diagnostics to Include Self-Collected Samples
SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, have added saliva to the list of validated samples for their PlexPCR® SARS-CoV-2 qPCR diagnostic for COVID-19 sales across Europe#.
April 21, 2022
·
3 min read
Business
Innovative Visionary Mark W. Womack Strengthens Bridgewest Perth Pharma Pty Ltd Board, Amplifying NovaCina’s Growth Vision
Bridgewest Perth Pharma, a global pharmaceutical supply and manufacturing company, with subsidiaries NovaCina and LumaCina, announced the appointment of Mark W. Womack as a Director of the Board.
March 5, 2024
·
3 min read
Press Releases
Tenpoint Therapeutics Ltd. to Participate at Citi Biotech Private Access Day
April 23, 2025
·
1 min read
Policy
SpeeDx Receives Clearance for COVID-19 Diagnostic Test
SpeeDx Pty. Ltd. announced their PlexPCR® SARS-CoV-2* test received clearance from the Australian Therapeutic Goods Administration.
August 11, 2021
·
4 min read
Press Releases
Tenpoint Therapeutics Ltd. to Participate in Upcoming Investor Conferences in April
April 1, 2025
·
2 min read
1 of 7,013
Next
